Application CT and MRI in Cerebral Venous Sinus Thrombosis

Magnetic Resonance Imaging Clinical Trial

Official title:

the Application CT and MRI in the Diagnosis of Cerebral Venous Sinus Thrombosis

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04966182
• Other study ID #: 2021-256
• Status: Recruiting
• Start date: January 1, 2015
• Est. completion date: January 1, 2022

Study information

• Verified date: July 2021
• Source: Second Affiliated Hospital, School of Medicine, Zhejiang University
• Contact: xu weilin, Ph.D
• Phone: +8618758140251
• Email: 11618330[@]zju.edu.cn
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Cerebral venous thrombosis (CVT) is a rare disease, and with poor prognosis. Computed tomography (CT) andmagnetic resonance imaging (MRI) are the most commonly used image modalities for patients with non-specific neurologic symptoms. We are going to assess the accuracy of CT and MRI in the differential diagnosis of CVT and cerebral venous sinus thrombosis (CVST).

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 120
• Est. completion date: January 1, 2022
• Est. primary completion date: January 1, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

A. The patients were diagnosed with cerebral venous thrombosis or cerebral venous sinus thrombosis; B. The patients completed at least cranial CT or MRI examination upon admission;C. The patients complete at least one of the CTV, MRV or DSA examination. Exclusion Criteria: A. Patients with severe cardiopulmonary insufficiency;B. Patients lost to follow-up;C. Patients with incomplete access to imaging data;D. Patients with cerebral venous sinus thrombosis that was not diagnosed at discharge.

Related Conditions & MeSH terms

• Cerebral Venous Sinus Thrombosis
• Magnetic Resonance Imaging
• Sinus Thrombosis, Intracranial
• Thrombosis

Locations

Country	Name	City	State
China	2nd Affiliated Hospital, School of Medicine, Zhejiang University	Hangzhou	Zhejiang

Sponsors (1)

Lead Sponsor	Collaborator
Second Affiliated Hospital, School of Medicine, Zhejiang University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	specificity and sensitivity of CT	specificity and sensitivity of CT in the diagnosis of cerebral venous sinus thrombosis	2022.01
Primary	specificity and sensitivity of MRI	specificity and sensitivity of MRI in the diagnosis of cerebral venous sinus thrombosis	2022.01